Two teenagers with T-cell acute lymphoblastic leukemia achieved complete molecular remission after receiving a donor-based investigational chimeric antigen receptor T-cell therapy, phase 1 study results showed.The patients — a 13-year-old girl and a 15-year-old boy — were among three study participants in the United Kingdom to receive the experimental CAR T-cell therapy as part of a